Senior Thought Leader Liaison - Neuroimmunology
Genentech · Las Vegas, NV · Commercial, Sales & Marketing
About this role
Genentech is hiring a senior-level Senior Thought Leader Liaison - Neuroimmunology based in Las Vegas, NV. Compensation is listed at $162,500–$301,700 per year.
- Level
- senior
- Employment
- Full-time
- Location
- Las Vegas, NV
- Department
- Commercial, Sales & Marketing
- Posted
- May 18, 2026
More roles at Genentech
Job description
from Genentech careersThe Position
Senior Thought Leader Liaison (TLL) - Neuroimmunology
We’re passionate about delivering on Our Promise to improve the lives of patients and create healthier communities for all. We foster a culture of inclusivity, integrity and creativity while boldly pursuing answers to the world’s most complex health challenges and transforming society.
The Opportunity:
The Senior TLL role at Genentech acts as the lead Commercial enterprise bridge to National & Regional Therapeutic Area Experts (TAEs) across Therapeutic Areas (TAs), operating as a proactive strategic partner who shapes markets and converts TAE influence into measurable results. The Senior TLL enables demand and patient access by serving as the trusted connection to priority TAEs, converting credibility into enterprise impact, translating scientific insights into commercial execution, and shaping TA narratives that drive belief, standard of care, and competitive positioning. The Senior TLL will demonstrate capabilities to translate TAE insights into actionable feedback to shape brand and squad strategies and execution. The role translates squad priorities into regional Customer Engagement (CE) opportunities and serves as the coordinated interface between external TAE engagement and internal strategy. TLLs operate with agility, adapting focus to evolving enterprise and portfolio priorities. Success in this role is demonstrated by accelerated speed to peak for priority launches, decision-shaping TAE engagement, and clear impact on therapeutic area and brand strategy based on outcome-based KPIs.